Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer
NCT01471470
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Advanced Gastric Cancer
Interventions
DRUG:
Docetaxel, Capecitabine, Cisplatin, Bevacizumab
Sponsor
Asan Medical Center
Collaborators
[object Object]